Evidence map›Paper›PMID 19922794›Full record

ArticleCellular signalling2010

Impaired TNF-alpha control of IP3R-mediated Ca2+ release in Alzheimer's disease mouse neurons.

Keigan M Park, David I Yule, William J Bowers

Abstract read
In one paragraph

Article in Cellular signalling, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Keigan M ParkDepartment of Pharmacology and Physiology, University of Rochester Medical Center, Rochester, NY 14642, USA.
David I Yule
William J Bowers
University of Rochester Medical Center · US

Funding

[Ca2+]i and Secretory Dynamics in Parotid Acinar CellsR01DE014756 · NIDCR · UNIVERSITY OF ROCHESTER · PI David I Yule · 2002 to 2026
$9.9M
TRAINING PROGRAM IN ORAL SCIENCET32DE007202 · NIDCR · UNIVERSITY OF ROCHESTER · PI QUIVEY, ROBERT G · 1990 to 2010
$5.5M
PANCREATIC SECRETION--G PROTEIN MEDIATED CA++ SIGNALINGR01DK054568 · NIDDK · UNIVERSITY OF ROCHESTER · PI YULE, DAVID I · 1998 to 2012
$3.1M
Gene-based TNF-alpha activity modulation in 3xTg-AD miceR01AG026328 · NIA · UNIVERSITY OF ROCHESTER · PI BOWERS, WILLIAM J. · 2007 to 2011
$1.4M
Novel Mouse Model to Dissect Alzheimer's Disease PathophysiologyR01AG023593 · NIA · UNIVERSITY OF ROCHESTER · PI BOWERS, WILLIAM J. · 2004 to 2008
$1.3M
Anti-obesity drug development using human preadipocytesR44DK054588 · NIDDK · ADIPOGENIX, INC. · PI WALOGA, GERALDINE · 2001 to 2002
$754k
Calcium Dysregulation and Inflammation in a Model of Alzheimer's DiseaseF31NS056731 · NINDS · UNIVERSITY OF ROCHESTER · PI PARK, KEIGAN M · 2007 to 2009
$90k
ENHANCED DIFFERENTIATION OF HUMAN PREADIPOCYTESR43DK054588 · NIDDK · ADIPOGENIX, INC. · PI WALOGA, GERALDINE · 1999 to 1999
–
NIA NIH HHS R01 AG023593NIA NIH HHS R01-AG023593NIA NIH HHS R01 AG026328NIA NIH HHS R01-AG026328NIDCR NIH HHS R01 DE014756NIDCR NIH HHS R01-DE14756NIDCR NIH HHS T32 DE007202NIDCR NIH HHS T32-DE07202NIDDK NIH HHS R01 DK054568NIDDK NIH HHS R01-DK54588NINDS NIH HHS F31 NS056731NINDS NIH HHS F31-NS056731
6 · The paper itself

Abstract

The misguided control of inflammatory signaling has been previously implicated in the pathogenesis of several neurological disorders, including Alzheimer's disease (AD). Induction of tumor necrosis factor-alpha (TNF-alpha), a central mediator of neuroinflammation, occurs commensurate with the onset of early disease in 3xTg-AD mice, which develop both amyloid plaque and neurofibrillary tangle pathologies in an age- and region-dependent pattern. Herein, we describe regulation inherent to 3xTg-AD neurons, which results in the loss of TNF-alpha mediated enhancement of inositol 1,4,5 trisphosphate (IP3R)-mediated Ca2+ release. This modulation also leads to significant down-regulation of IP3R signaling following protracted cytokine exposure. Through the experimental isolation of each AD-related transgene, it was determined that expression of the PS1M146V transgene product is responsible for the loss of the TNF-alpha effect on IP3R-mediated Ca2+ release. Furthermore, it was determined that the suppression of TNF-alpha receptor expression occurred in the presence of the presenilin transgene. Our findings attribute this familial AD mutation to suppressing a Ca2+-regulated signal cascade potentially intended to "inform" neurons of proximal neuroinflammatory events and trigger compensatory responses for protection of neural transmission.

Indexed as

Alzheimer DiseaseAnimalsCalciumCells, CulturedInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsMiceNeuronsPresenilinsReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRNA, Small InterferingTumor Necrosis Factor-alphaCalciumInositol 1,4,5-TrisphosphateInositol 1,4,5-Trisphosphate ReceptorsPresenilinsReceptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIRNA, Small InterferingTumor Necrosis Factor-alpha

Identifiers

PMID19922794
PMCPMC2794907
OpenAlexW2068177436

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.